gptkbp:instance_of
|
gptkb:drug
|
gptkbp:approves
|
gptkb:legislation
gptkb:1998
gptkb:United_States
|
gptkbp:brand
|
gptkb:Foradil
|
gptkbp:can_be_used_with
|
anticholinergics
inhaled corticosteroids
|
gptkbp:class
|
long-acting beta-agonist
|
gptkbp:clinical_trial
|
Phase III
maintenance therapy
|
gptkbp:contraindication
|
hypersensitivity to formoterol
severe asthma exacerbation
|
gptkbp:dosage_form
|
gptkb:superhero
12 mcg twice daily
|
gptkbp:duration
|
up to 12 hours
|
gptkbp:excretion
|
urine
|
gptkbp:form
|
aerosol
|
https://www.w3.org/2000/01/rdf-schema#label
|
Foradil
|
gptkbp:ingredients
|
gptkb:formoterol
|
gptkbp:interacts_with
|
MAO inhibitors
diuretics
beta-blockers
|
gptkbp:is_atype_of
|
R03 A C13
|
gptkbp:is_used_for
|
gptkb:asthma
chronic obstructive pulmonary disease
|
gptkbp:legal_issue
|
prescription only
|
gptkbp:lifespan
|
8-10 hours
|
gptkbp:manager
|
inhalation
|
gptkbp:manufacturer
|
gptkb:temple
|
gptkbp:marketed_as
|
gptkb:Foradil_Aerolizer
|
gptkbp:metabolism
|
liver
|
gptkbp:name
|
Essential Medicines
|
gptkbp:packaging
|
pressurized metered-dose inhaler
|
gptkbp:population
|
available online
|
gptkbp:premiered_on
|
within 15 minutes
|
gptkbp:previous_name
|
gptkb:formoterol_fumarate
|
gptkbp:related_to
|
gptkb:budesonide
salbutamol
|
gptkbp:requires
|
available online
|
gptkbp:safety_features
|
available online
|
gptkbp:side_effect
|
dizziness
headache
nausea
cough
hypokalemia
nervousness
palpitations
throat irritation
hyperglycemia
tremor
|
gptkbp:storage
|
room temperature
protected from light
|
gptkbp:bfsParent
|
gptkb:formoterol
gptkb:formoterol_fumarate
|
gptkbp:bfsLayer
|
5
|